NCT01442298

Brief Summary

The use of bloodless field is a helpful and important method in orthopedic surgery. The surgery can be done without interrupting bleedings, while keeping an exact overlook of the anatomy. However the method is not without risks, and complications of various kind may occur. One of the most important factors to minimise the risk of complications, is to keep the lowest possible cuff pressure. Previous electromyography (EMG) studies have indicated neuromuscular abnormalities after bloodless field among many patients which may lead to a prolonged rehabilitation period since they cause a postoperative weakness in the muscles. Although in these studies an unnecessary high tourniquet pressures were used and the EMG tests were made 6 weeks and 6 months after the surgery. With today's demand for fast rehabilitation, there is a need for better knowledge if lower tourniquet pressure in bloodless field surgery may lead to less neuromuscular abnormalities. Limb Occlusion Pressure (LOP) is the tourniquet cuff pressure required to occlude the blood flow. It accounts for a patients limb and vessel characteristics and the type and fit of the tourniquet cuff. The method has developed and is now simplified, by using an automatic (plethysmographic) sensor placed on the second toe on the involved limb, and after administration of anaesthesia, and immediately before limb preparation and draping it measures the limb occlusion pressure. When surgery starts, the cuff is inflated again; plus a safety margin based on the LOP pressure measured. The LOP method is still rarely used it has been seen as difficult and time consuming. The primary aim of this study is to investigate whether you can reduce the used tourniquet pressure with the new LOP measurement technique and still have a adequate bloodless field; and if this will lead to any clinical difference regarding postoperative pain. The secondary aim is to investigate the difference between the test groups concerning muscle function and wound healing and if these are remaining and of clinical importance. The third aim is to study how common neuromuscular abnormalities are after the use of bloodless field with lower cuff pressures and if there are any differences between the standard method and the LOP method.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
164

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2008

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2008

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2010

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

September 2, 2011

Completed
26 days until next milestone

First Posted

Study publicly available on registry

September 28, 2011

Completed
Last Updated

September 28, 2011

Status Verified

September 1, 2011

Enrollment Period

1.7 years

First QC Date

September 2, 2011

Last Update Submit

September 27, 2011

Conditions

Keywords

bloodless fieldcuff pressurelimb occlusion pressure

Outcome Measures

Primary Outcomes (2)

  • Cuff pressure (mmHg)

    For patients in the control group the tourniquet cuff pressure was based on the patient's systolic blood pressure and a margin that were decided by the surgeon. In the LOP group the tourniquet cuff pressure were decided by measurement of limb occlusion pressure (LOP) by using an automated photo plethysmographic sensor connected to a ATS 3000 tourniquet apparatus

    participantswill be followed for the duration of hospital stay , an expected avarage of 4-5 days

  • Quality of bloodless field

    Direct after surgery the surgeon rated the quality of bloodless fiels on a visual analog scale (VAS)

    particpants will be followed for the duration of the hospital stay, an expected avarage of 4-5 days

Secondary Outcomes (4)

  • Postoperative pain

    The participants were followed daily during their hospital stay (4-5 days) and at the two months follow up after surgery

  • Range of motion (ROM)

    The participants were examined at third postoperative day and at the two months follow up after surgery

  • Postoperative wound complications

    The participants were examined at discharged (day 4 or 5 postoperatively) and at the two months follow up after surgery

  • EMG/EnEG

    Participans were examined day three and two months postoperatively

Study Arms (2)

conventional treatment

ACTIVE COMPARATOR

the Standard method;tourniquet pressure based on systolic blood pressure, plus a safety margin.

Procedure: conventional measurement method

limb occlusion pressure(LOP)

EXPERIMENTAL

cuff pressure is based on limb occlusion pressure measurement

Procedure: Limb occlusion pressure (LOP)

Interventions

The tourniquet cuff pressure were decided by measurement of limb occlusion pressure (LOP) using an automated photo plethysmographic sensor connected to a ATS 3000 tourniquet apparatus (Zimmer Sweden Inc®).

limb occlusion pressure(LOP)

Standard method at our department, the tourniquet cuff pressure was based on the patient's systolic blood pressure and a margin that were decided by the surgeon.

conventional treatment

Eligibility Criteria

AgeUp to 75 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Planned for total knee arthroplasty in bloodless field
  • year or younger

You may not qualify if:

  • Patients unable to read and understand Swedish
  • Systolic blood pressure over 200 mmHg and a girth of the thigh over 78 cm was excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of clinical science and education, Södersjukhuset

Stockholm, 11883, Sweden

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
RN nurse, OR nurse

Study Record Dates

First Submitted

September 2, 2011

First Posted

September 28, 2011

Study Start

October 1, 2008

Primary Completion

July 1, 2010

Study Completion

October 1, 2010

Last Updated

September 28, 2011

Record last verified: 2011-09

Locations